Octapharma gets Octagam 10% FDA approval for adult dermatomyositis
Octapharma USA has secured approval for Octagam 10% [Immune Globulin Intravenous (Human)] from the US Food and Drug Administration (FDA) for the treatment of adult dermatomyositis. The company, which is a subsidiary of Swiss human protein manufacturer Octapharma, said that Octagam 10% is the first and only intravenous immunoglobulin (IVIg) to have been indicated by […]